Get this report today!
Table of Contents
There is much discussion about emerging markets in in vitro diagnostics, especially the BRIC nations - Brazil, Russia, India and China. Which companies have been successful in these markets and how have they accomplished it? What kind of realistic growth can marketers expect by selling products in these areas? This report is intended to provide an overview of trends and developments in the in IVD industry as it applies to emerging markets and the BRIC countries in particular.
A Realistic Look at the Market for IVD in New, Emerging Markets
A good number of reports on the BRIC and emerging markets have been published. Most of these focus on quantitative data such as number of labs, hospitals, product registration regulations, and import taxes and conditions. Too many of them perhaps present merely a growth scenario without presenting the challenges the nations face and the challenges the countries face entering the market. This report provides much of this information because it provides an objective overview of the market for in vitro diagnostics in selected countries. This report also explores the opportunities that specific developing countries offer to IVD companies.
Kalorama also attempts to add some realistic aspects of working in a foreign country that are more qualitative in nature. Thus the report explores some of the cultural aspects of how the market for clinical diagnostics may evolve in a selection of emerging markets including the BRIC countries.
Useful Information for Business Planning
The discussion of each of the BRIC markets begins with a short introduction to the country and follows with a SWOT analysis of the market for IVDs. The SWOT analysis provides positive and negative aspects of market conditions. The author has decided to include positive and negative aspects of certain factors in the same SWOT category. The factors are classed positive or negative according to the strength of current market conditions. This is done to make the analysis comprehensive and easier to read.
The report covers data trends and issues, including:
Talk to Robyn
+1 718 213 4904
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
MediPoint: In-Vitro Colorectal Cancer Screening Tests - Global Analysis and Market Forecasts Summary Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause ...
INTRODUCTION BCC Research measures and segments the flow cytometry market on the basis of instruments, reagents, software, services, technologies, applications and end users. Key instruments discussed ...
Enteric Disease Testing Market (Amebiasis, C.Difficile Infection, Campylobacteriosis, Cholera, Cryptosporidiosis, E.Coli Infection, Giardiasis, H.Pylori Infection, Norovirus Infection, Rotavirus Infection, ...
... Colposcopy repeat hpv + pap after 12 months referral to a general practitioner for extra sample: pap smear extra sampling step after hpv+ test should be avoided dna delphi self- sample molecular triage ...
... Contracted over the first six months, impacted by weak demand in southern europe and the consolidation of clinical laboratories in france. After a particularly challenging first quarter ...
Reportlinker.com © Copyright 2013. All rights reserved.